SGC-SMARCA-BRDVIII
SGC-SMARCA-BRDVIII, a chemical probe, is a potent and selective inhibitor of SMARCA2/4 and PB1 (5), with Kds of 35 nM, 36 nM, and 13 nM, respectively. SGC-SMARCA-BRDVIII also inhibits PB1 (2) and PB1 (3), with Kds of 3.7 and 2.0 μM, respectively. SGC-SMARCA-BRDVIII can block adipogenesis of 3T3-L1 murine fibroblasts[1][2].
Product Specifications
CAS Number
1997319-84-2
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/sgc-smarca-brdviii.html
Concentration
10mM
Purity
99.66
Solubility
DMSO : 23.33 mg/mL (ultrasonic)
Smiles
O=C(N1CCN(CC1)C2=C(N)N=NC(C3=CC=CC=C3O)=C2)OC(C)(C)C
Molecular Formula
C19H25N5O3
Molecular Weight
371.43
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Filaggrin (Keratinocyte Differentiation Marker) (FLG/1563), Biotin conjugate, 0.1mg/mL
Chromogranin A (CHGA/765), CF640R conjugate, 0.1mg/mL
CD3e Mouse Monoclonal Antibody (SK7), R-PE Conjugate - Biotium Choice
